Loading…

Cytochrome P450 3A expression and function in liver and intestinal mucosa from dexamethasone‐treated sheep

Maté, M. L., Lifschitz, A., Sallovitz, J., Ballent, M., Muscher, A. S., Wilkens, M. R., Schröder, B., Lanusse, C., Virkel, G. Cytochrome P450 3A expression and function in liver and intestinal mucosa from dexamethasone‐treated sheep. J. vet. Pharmacol. Therap. 35, 319–328. The effects of repeated ad...

Full description

Saved in:
Bibliographic Details
Published in:Journal of veterinary pharmacology and therapeutics 2012-08, Vol.35 (4), p.319-328
Main Authors: MATÉ, M. L, LIFSCHITZ, A, SALLOVITZ, J, BALLENT, M, MUSCHER, A. S, WILKENS, M. R, SCHRÖDER, B, LANUSSE, C, VIRKEL, G
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Maté, M. L., Lifschitz, A., Sallovitz, J., Ballent, M., Muscher, A. S., Wilkens, M. R., Schröder, B., Lanusse, C., Virkel, G. Cytochrome P450 3A expression and function in liver and intestinal mucosa from dexamethasone‐treated sheep. J. vet. Pharmacol. Therap. 35, 319–328. The effects of repeated administrations of dexamethasone (DEX) (3 mg/kg/day by IM route for 7 days) on the gene expression profile of a cytochrome P450 (CYP) 3A28‐like isoenzyme, on the expression of a CYP3A‐immunoreactive protein and on CYP3A‐dependent metabolic activities in sheep liver and small intestinal mucosa were evaluated in the current work. CYP 3A‐dependent metabolic activities (erythromycin and triacetyl‐oleandomycin N‐demethylations) were assessed in microsomal fractions. The mRNA expression of CYP3A28‐like, glucocorticoid receptor, constitutive androstane receptor, pregnane X receptor and retinoic X receptor alpha (RXRα) was determined by quantitative real‐time PCR. The expression of a CYP3A‐immunoreactive protein was measured by Western blot analyses. In the liver, DEX treatment increased CYP3A28‐like mRNA levels (2.67‐fold, P 
ISSN:0140-7783
1365-2885
DOI:10.1111/j.1365-2885.2011.01334.x